Exane Derivatives’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,766
| Closed | -$1.04M | – | 933 |
|
|
2022
Q1 | $1.04M | Buy |
+1,766
| New | +$1.04M | 0.29% | 87 |
|
|
2021
Q4 | – | Sell |
-4,194
| Closed | -$2.4M | – | 971 |
|
|
2021
Q3 | $2.4M | Buy |
4,194
+93
| +2% | +$53.1K | 0.58% | 29 |
|
|
2021
Q2 | $2.11M | Buy |
4,101
+643
| +19% | +$331K | 0.48% | 37 |
|
|
2021
Q1 | $1.58M | Sell |
3,458
-989
| -22% | -$451K | 0.45% | 42 |
|
|
2020
Q4 | $2.07M | Buy |
4,447
+682
| +18% | +$318K | 0.61% | 29 |
|
|
2020
Q3 | $1.66M | Sell |
3,765
-31
| -0.8% | -$13.7K | 0.48% | 38 |
|
|
2020
Q2 | $1.38M | Buy |
3,796
+868
| +30% | +$314K | 0.37% | 70 |
|
|
2020
Q1 | $830K | Sell |
2,928
-852
| -23% | -$242K | 0.23% | 82 |
|
|
2019
Q4 | $1.27M | Sell |
3,780
-240
| -6% | -$80.4K | 0.23% | 94 |
|
|
2019
Q3 | $1.17M | Buy |
4,020
+1,856
| +86% | +$540K | 0.21% | 88 |
|
|
2019
Q2 | $635K | Buy |
2,164
+1,817
| +524% | +$533K | 0.11% | 136 |
|
|
2019
Q1 | $94.9K | Buy |
347
+173
| +99% | +$47.3K | 0.02% | 282 |
|
|
2018
Q4 | $38.9K | Buy |
+174
| New | +$38.9K | 0.01% | 355 |
|
|
2017
Q1 | – | Sell |
-2,558
| Closed | -$361K | – | 628 |
|
|
2016
Q4 | $361K | Sell |
2,558
-24,857
| -91% | -$3.51M | 0.07% | 159 |
|
|
2016
Q3 | $4.36M | Buy |
27,415
+18,899
| +222% | +$3.01M | 0.65% | 41 |
|
|
2016
Q2 | $1.26M | Buy |
+8,516
| New | +$1.26M | 0.21% | 74 |
|
|
2015
Q4 | – | Sell |
-330
| Closed | -$40.4K | – | 513 |
|
|
2015
Q3 | $40.4K | Buy |
+330
| New | +$40.4K | 0.01% | 246 |
|